TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
TCL Archive NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner. June 2, 2006
TCL Archive In Brief: The Children’s Oncology Group Is Name for Pediatric Trials Groups In Merger June 25, 1999
